Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk’s <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> Wegovy were still taking it a year later, while total healthcare costs for t…